Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data

BACKGROUND: Individual patient meta-analysis to determine the analgesic efficacy and adverse effects of single-dose rofecoxib in primary dysmenorrhoea. METHODS: Individual patient information was available from three randomised, double blind, placebo and active controlled trials of rofecoxib. Data w...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Jayne E, Moore, R Andrew, McQuay, Henry J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC493273/
https://www.ncbi.nlm.nih.gov/pubmed/15265230
http://dx.doi.org/10.1186/1472-6874-4-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC493273/
https://www.ncbi.nlm.nih.gov/pubmed/15265230
http://dx.doi.org/10.1186/1472-6874-4-5

Ejemplares similares